以降钙素基因高度甲基化为分子基因标志检测白血病微量残留病  被引量:3

Hypermethylation of the calcitonin gene as molecular genetic marker in detecting minimal residual disease of leukemia

在线阅读下载全文

作  者:唐义平[1] 邓承祺[2] 杜琼[1] 李戈[1] 曾昭惠[1] 张晋琳[1] 缪世锟[1] 成都 

机构地区:[1]四川省人民医院血液科 610072 [2]华西医科大学附属第一医院血液科

出  处:《中华内科杂志》2001年第4期226-228,共3页Chinese Journal of Internal Medicine

摘  要:目的 探讨以降钙素(CT)基因高度甲基化为白血病克隆的分子基因标志,检测白血病微量残留病(MRD),并预测预后的可能性。方法 用限制性内切酶消化DNA,应用聚合酶链反应(PCR)技术检测29例急性白血病(AL),其中急性淋巴细胞白血病(ALL)14例,急性非淋巴细胞白血病(ANLL)15例和8例慢性粒细胞白血病(CML)急变患者的CT基因的甲基化程度。对CT基因高度甲基化阳性者,以CT基因高度甲基化为白血病克隆的分子基因标志,应用PCR技术定期追踪检测骨髓MRD。结果 ALL中CT基因高度甲基化阳性率为85.7%(12/14),ANLL为60%(9/15),CML急变为100%(8/8),而对照组无一例阳性。20例AL和CML急变患者完全缓解(CR)后均存在MRD。CR后MRD持续阳性或转阴后再次出现阳性,提示将发生骨髓复发,能提早2~11个月预示疾病的复发。MRD较早转阴并持续长期阴性者可能获得长期生存。结论 以CT基因高度甲基化为白血病克隆的分子基因标志,应用PCR技术能起到监测白血病MRD的作用,为预测白血病的预后开辟了一条新途径。Objective: To explore whether detecting minimal residual disease (MRD) of leukemia with hypermethylation of the calcitonin gene as molecular genetic marker of leukemic clone may predict the prognosis. Methods: Polymerase chain reaction (PCR) in combination with digestion of DNA with HpaⅡ was used to examine the methylation patterns of the calcitonin gene in 29 cases with acute leukemia and 8 cases with transformation of chronic myeloid leukemia. By using PCR, MRD was longitudinally detected in patients who were positive for hypermethylation of the calcitonin gene as molecular genetic marker. Results Twenty patients with acute leukemia and transformation of chronic myeloid leukemia had MRD after complete remission. Bone marrow relapse occurred soon when MRD persisted or reappeared. It may predict bone marrow relapse two to eleven months earlier. The patients who were negative for MRD early and remained persistently negative may acquire prolonged survival.Conclusion MRD of leukemia may be monitored by using PCR with hypermethylation of the calcitonin gene as molecular genetic marker for leukemic clone. It may prove useful in predicting the prognosis of leukemia.

关 键 词:白血病 残余肿瘤 降钙素 聚合酶链反应 高度甲基化 分子基因标志 MRD 

分 类 号:R733.7[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象